Amyloidosis Clinical Trials

ReadTheTrial indexes 3 studies for Amyloidosis. The most common development stage is N/A (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Amyloidosis.

Pipeline by Phase

PhaseTrialsDistribution
N/A 2
67%
Phase 3 1
33%

Trial Status Breakdown

Trials for Amyloidosis

Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis

NCT07494942 · NOT YET RECRUITING · N/A

A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial)

NCT06563895 · RECRUITING · Phase 3

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

NCT03431896 · COMPLETED · N/A

Frequently Asked Questions

What clinical trials are available for Amyloidosis?

There are 3 clinical trials listed for Amyloidosis. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Amyloidosis trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Amyloidosis trials in?

Current Amyloidosis trials are distributed across: N/A (2), Phase 3 (1).

Find More Trials